GSK3B and urinary bladder carcinoma: Moreover, targeting GSK3β with 9-ING-41 (a small molecule inhibitor of GSK3β) has been observed to have multiple anti-bladder cancer effects, including cell cycle arrest, autophagy, and apoptosis in bladder cancer cells.